Review



biotinylated polyclonal goat anti human cxcl8 antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems biotinylated polyclonal goat anti human cxcl8 antibody
    Figure 5. The MIG30 peptide does not affect the responsiveness or activation status of leukocytes towards stimuli. (A) Intracellular calcium signal ([Ca2+]i in nM) in purified human neutrophils loaded with Fura-2/AM and stimulated with <t>CXCL8</t> (10 ng/mL) and/or MIG30 (20 µg/mL). Results
    Biotinylated Polyclonal Goat Anti Human Cxcl8 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 76 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+polyclonal+goat+anti+human+cxcl8+antibody/Human+IL-8%2FCXCL8+Biotinylated+Antibody/pm36077113-365-6-13
    Average 93 stars, based on 76 article reviews
    biotinylated polyclonal goat anti human cxcl8 antibody - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice."

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice.

    Journal: International journal of molecular sciences

    doi: 10.3390/ijms23179715

    Figure 5. The MIG30 peptide does not affect the responsiveness or activation status of leukocytes towards stimuli. (A) Intracellular calcium signal ([Ca2+]i in nM) in purified human neutrophils loaded with Fura-2/AM and stimulated with CXCL8 (10 ng/mL) and/or MIG30 (20 µg/mL). Results
    Figure Legend Snippet: Figure 5. The MIG30 peptide does not affect the responsiveness or activation status of leukocytes towards stimuli. (A) Intracellular calcium signal ([Ca2+]i in nM) in purified human neutrophils loaded with Fura-2/AM and stimulated with CXCL8 (10 ng/mL) and/or MIG30 (20 µg/mL). Results

    Techniques Used: Activation Assay

    Related Articles

    Activation Assay:

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice.
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 ◦C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 °C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .

    Purification:

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice.
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 ◦C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 °C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .

    Incubation:

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice.
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 ◦C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 °C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .

    Enzyme-linked Immunosorbent Assay:

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice.
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 ◦C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 °C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .

    Flow Cytometry:

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice.
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 ◦C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 °C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .

    Expressing:

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice.
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 ◦C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 °C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .

    Fluorescence:

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice.
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 ◦C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 °C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .

    Concentration Assay:

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice.
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 ◦C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 ◦C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.The incubation of peroxidase-conjugated streptavidin for 30 min at 37 ◦C allowed the oxidation of TMB substrate in the presence of H2O2, after which the reaction was stopped by adding 1 M H2SO4.

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice
    Article Snippet: Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.Plates were blocked with PBS with 0.1% casein and 0.05% Tween 20 for 1 h at 37 °C.. Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 °C.. The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .The incubation of peroxidase-conjugated streptavidin for 30 min at 37 °C allowed the oxidation of TMB substrate in the presence of H 2 O 2 , after which the reaction was stopped by adding 1 M H 2 SO 4 .



    Similar Products

    human il-8/cxcl8 biotinylated antibody  (Bio-Techne corporation)
    93
    Bio-Techne corporation human il-8/cxcl8 biotinylated antibody
    Human Il 8/Cxcl8 Biotinylated Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+polyclonal+goat+anti+human+cxcl8+antibody/Human+IL-8%2FCXCL8+Biotinylated+Antibody/bio-techne+corporation___baf208
    Average 93 stars, based on 1 article reviews
    human il-8/cxcl8 biotinylated antibody - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    biotinylated polyclonal goat anti human cxcl8 antibody  (R&D Systems)
    93
    R&D Systems biotinylated polyclonal goat anti human cxcl8 antibody
    Figure 5. The MIG30 peptide does not affect the responsiveness or activation status of leukocytes towards stimuli. (A) Intracellular calcium signal ([Ca2+]i in nM) in purified human neutrophils loaded with Fura-2/AM and stimulated with <t>CXCL8</t> (10 ng/mL) and/or MIG30 (20 µg/mL). Results
    Biotinylated Polyclonal Goat Anti Human Cxcl8 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+polyclonal+goat+anti+human+cxcl8+antibody/Human+IL-8%2FCXCL8+Biotinylated+Antibody/pm36077113-365-6-13
    Average 93 stars, based on 1 article reviews
    biotinylated polyclonal goat anti human cxcl8 antibody - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    polyclonal goat anti human cxcl8 baf208 antibodies  (R&D Systems)
    93
    R&D Systems polyclonal goat anti human cxcl8 baf208 antibodies
    hrSAA1 does not induce chemokine expression in CD14 + monocytes and treatment of rSAA1 with LPL diminishes activity. (A,C) Freshly isolated monocytes were induced with homogenous rSAA1 (hrSAA1) (1–12000 ng/ml, 0.08–1000 nM) in parallel with rSAA1 (1–12000 ng/ml, 0.08–1000 nM). (B,D) rSAA1 (100 ng/ml, 8 nM) was pre-incubated with LPL (2000 ng/ml) for 4 h prior to stimulation of monocytes. Following an incubation period of 24 h, cell supernatants were collected and <t>CXCL8</t> and CCL3 expression was determined via specific ELISAs. Expression in unstimulated cells is indicated by a dashed line (—). Results are represented as the mean chemokine concentration + SEM and are derived from four to six independent experiments. Significant upregulation in comparison to control is indicated by asterisks (Mann-Whitney U -test; * p -value < 0.05, ** p -value < 0.01). Significant reduction in inductive capacity following LPL treatment is indicated by a dagger (Mann-Whitney U -test; † p -value < 0.05).
    Polyclonal Goat Anti Human Cxcl8 Baf208 Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+polyclonal+goat+anti+human+cxcl8+antibody/Human+IL-8%2FCXCL8+Biotinylated+Antibody/pmc07240019-99-16-23
    Average 93 stars, based on 1 article reviews
    polyclonal goat anti human cxcl8 baf208 antibodies - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    biotinylated polyclonal goat anti human cxcl8 baf208 antibodies  (R&D Systems)
    93
    R&D Systems biotinylated polyclonal goat anti human cxcl8 baf208 antibodies
    Impure mu rSAA3 induces chemokines in human CD14 + monocytes. Human CD14 + monocytes derived from buffy coats of healthy individuals were stimulated with LPS (500 ng/ml), hu rSAA1 (100 or 1000 ng/ml), mu rSAA3 (10-1000 ng/ml) or were left untreated (Co). After 24 h, supernatants were collected and levels of <t>CXCL8,</t> CCL3 and CCL2 were determined via specific ELISAs. Data represent the mean production of chemokine ± SEM derived from 4 independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05).
    Biotinylated Polyclonal Goat Anti Human Cxcl8 Baf208 Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+polyclonal+goat+anti+human+cxcl8+antibody/Human+IL-8%2FCXCL8+Biotinylated+Antibody/pmc07362292-73-16-25
    Average 93 stars, based on 1 article reviews
    biotinylated polyclonal goat anti human cxcl8 baf208 antibodies - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    biotinylated polyclonal goat anti human il  (R&D Systems)
    93
    R&D Systems biotinylated polyclonal goat anti human il
    Impure mu rSAA3 induces chemokines in human CD14 + monocytes. Human CD14 + monocytes derived from buffy coats of healthy individuals were stimulated with LPS (500 ng/ml), hu rSAA1 (100 or 1000 ng/ml), mu rSAA3 (10-1000 ng/ml) or were left untreated (Co). After 24 h, supernatants were collected and levels of <t>CXCL8,</t> CCL3 and CCL2 were determined via specific ELISAs. Data represent the mean production of chemokine ± SEM derived from 4 independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05).
    Biotinylated Polyclonal Goat Anti Human Il, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+polyclonal+goat+anti+human+cxcl8+antibody/Human+IL-8%2FCXCL8+Biotinylated+Antibody/pm24091714-98-0-16
    Average 93 stars, based on 1 article reviews
    biotinylated polyclonal goat anti human il - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    biotinylated polyclonal goat anti human il 8 antibody  (R&D Systems)
    93
    R&D Systems biotinylated polyclonal goat anti human il 8 antibody
    Impure mu rSAA3 induces chemokines in human CD14 + monocytes. Human CD14 + monocytes derived from buffy coats of healthy individuals were stimulated with LPS (500 ng/ml), hu rSAA1 (100 or 1000 ng/ml), mu rSAA3 (10-1000 ng/ml) or were left untreated (Co). After 24 h, supernatants were collected and levels of <t>CXCL8,</t> CCL3 and CCL2 were determined via specific ELISAs. Data represent the mean production of chemokine ± SEM derived from 4 independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05).
    Biotinylated Polyclonal Goat Anti Human Il 8 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+polyclonal+goat+anti+human+cxcl8+antibody/Human+IL-8%2FCXCL8+Biotinylated+Antibody/pm22366056-86-0-9
    Average 93 stars, based on 1 article reviews
    biotinylated polyclonal goat anti human il 8 antibody - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    biotinylated polyclonal goat anti human il 8 detection antibody  (R&D Systems)
    93
    R&D Systems biotinylated polyclonal goat anti human il 8 detection antibody
    Impure mu rSAA3 induces chemokines in human CD14 + monocytes. Human CD14 + monocytes derived from buffy coats of healthy individuals were stimulated with LPS (500 ng/ml), hu rSAA1 (100 or 1000 ng/ml), mu rSAA3 (10-1000 ng/ml) or were left untreated (Co). After 24 h, supernatants were collected and levels of <t>CXCL8,</t> CCL3 and CCL2 were determined via specific ELISAs. Data represent the mean production of chemokine ± SEM derived from 4 independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05).
    Biotinylated Polyclonal Goat Anti Human Il 8 Detection Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+polyclonal+goat+anti+human+cxcl8+antibody/Human+IL-8%2FCXCL8+Biotinylated+Antibody/pmc03047791-79-9-18
    Average 93 stars, based on 1 article reviews
    biotinylated polyclonal goat anti human il 8 detection antibody - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    goat polyclonal anti human il 8  (R&D Systems)
    93
    R&D Systems goat polyclonal anti human il 8
    Impure mu rSAA3 induces chemokines in human CD14 + monocytes. Human CD14 + monocytes derived from buffy coats of healthy individuals were stimulated with LPS (500 ng/ml), hu rSAA1 (100 or 1000 ng/ml), mu rSAA3 (10-1000 ng/ml) or were left untreated (Co). After 24 h, supernatants were collected and levels of <t>CXCL8,</t> CCL3 and CCL2 were determined via specific ELISAs. Data represent the mean production of chemokine ± SEM derived from 4 independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05).
    Goat Polyclonal Anti Human Il 8, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+polyclonal+goat+anti+human+cxcl8+antibody/Human+IL-8%2FCXCL8+Biotinylated+Antibody/pmc02838669-222-33-37
    Average 93 stars, based on 1 article reviews
    goat polyclonal anti human il 8 - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    goat polyclonal biotinylated anti human il 8 antibody  (R&D Systems)
    93
    R&D Systems goat polyclonal biotinylated anti human il 8 antibody
    Impure mu rSAA3 induces chemokines in human CD14 + monocytes. Human CD14 + monocytes derived from buffy coats of healthy individuals were stimulated with LPS (500 ng/ml), hu rSAA1 (100 or 1000 ng/ml), mu rSAA3 (10-1000 ng/ml) or were left untreated (Co). After 24 h, supernatants were collected and levels of <t>CXCL8,</t> CCL3 and CCL2 were determined via specific ELISAs. Data represent the mean production of chemokine ± SEM derived from 4 independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05).
    Goat Polyclonal Biotinylated Anti Human Il 8 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+polyclonal+goat+anti+human+cxcl8+antibody/Human+IL-8%2FCXCL8+Biotinylated+Antibody/10__1515_slash_cclm__2010__259-36-10-20
    Average 93 stars, based on 1 article reviews
    goat polyclonal biotinylated anti human il 8 antibody - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 5. The MIG30 peptide does not affect the responsiveness or activation status of leukocytes towards stimuli. (A) Intracellular calcium signal ([Ca2+]i in nM) in purified human neutrophils loaded with Fura-2/AM and stimulated with CXCL8 (10 ng/mL) and/or MIG30 (20 µg/mL). Results

    Journal: International journal of molecular sciences

    Article Title: The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice.

    doi: 10.3390/ijms23179715

    Figure Lengend Snippet: Figure 5. The MIG30 peptide does not affect the responsiveness or activation status of leukocytes towards stimuli. (A) Intracellular calcium signal ([Ca2+]i in nM) in purified human neutrophils loaded with Fura-2/AM and stimulated with CXCL8 (10 ng/mL) and/or MIG30 (20 µg/mL). Results

    Article Snippet: Detection was performed with 250 ng/mL biotinylated polyclonal goat anti-human CXCL8 antibody (BAF208, R&D Systems) for 1 h at 37 ◦C.

    Techniques: Activation Assay

    hrSAA1 does not induce chemokine expression in CD14 + monocytes and treatment of rSAA1 with LPL diminishes activity. (A,C) Freshly isolated monocytes were induced with homogenous rSAA1 (hrSAA1) (1–12000 ng/ml, 0.08–1000 nM) in parallel with rSAA1 (1–12000 ng/ml, 0.08–1000 nM). (B,D) rSAA1 (100 ng/ml, 8 nM) was pre-incubated with LPL (2000 ng/ml) for 4 h prior to stimulation of monocytes. Following an incubation period of 24 h, cell supernatants were collected and CXCL8 and CCL3 expression was determined via specific ELISAs. Expression in unstimulated cells is indicated by a dashed line (—). Results are represented as the mean chemokine concentration + SEM and are derived from four to six independent experiments. Significant upregulation in comparison to control is indicated by asterisks (Mann-Whitney U -test; * p -value < 0.05, ** p -value < 0.01). Significant reduction in inductive capacity following LPL treatment is indicated by a dagger (Mann-Whitney U -test; † p -value < 0.05).

    Journal: Frontiers in Immunology

    Article Title: Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1

    doi: 10.3389/fimmu.2020.00843

    Figure Lengend Snippet: hrSAA1 does not induce chemokine expression in CD14 + monocytes and treatment of rSAA1 with LPL diminishes activity. (A,C) Freshly isolated monocytes were induced with homogenous rSAA1 (hrSAA1) (1–12000 ng/ml, 0.08–1000 nM) in parallel with rSAA1 (1–12000 ng/ml, 0.08–1000 nM). (B,D) rSAA1 (100 ng/ml, 8 nM) was pre-incubated with LPL (2000 ng/ml) for 4 h prior to stimulation of monocytes. Following an incubation period of 24 h, cell supernatants were collected and CXCL8 and CCL3 expression was determined via specific ELISAs. Expression in unstimulated cells is indicated by a dashed line (—). Results are represented as the mean chemokine concentration + SEM and are derived from four to six independent experiments. Significant upregulation in comparison to control is indicated by asterisks (Mann-Whitney U -test; * p -value < 0.05, ** p -value < 0.01). Significant reduction in inductive capacity following LPL treatment is indicated by a dagger (Mann-Whitney U -test; † p -value < 0.05).

    Article Snippet: The human CXCL8 ELISA was developed in our laboratory using monoclonal mouse anti-human CXCL8 (MAB208) and polyclonal goat anti-human CXCL8 (BAF208) antibodies from R&D Systems ( ).

    Techniques: Expressing, Activity Assay, Isolation, Incubation, Concentration Assay, Derivative Assay, Comparison, Control, MANN-WHITNEY

    hrSAA1 retains the capacity to synergize with CXCL8 in the in vitro attraction and activation of neutrophils. (A) Homogenous rSAA1 (hrSAA1, 300 or 3000 ng/ml, 25 or 250 nM) and CXCL8 (1–10 ng/ml, 0.12–1.2 nM) were added to the lower compartment of a Boyden microchamber either alone or in combination. Freshly isolated neutrophils were added to the upper compartment and allowed to migrate for 45 min. The chemotactic potencies are expressed as mean chemotactic index (+SEM) derived from six independent experiments. Control recruitment is indicated by a dashed line (—). (B) MMK-1 (16 μg/ml, 9930 nM), hrSAA1 (3000 ng/ml, 250 nM), CXCL8 (3 or 9 ng/ml, 0.36 or 1.07 nM) or a combination of hrSAA1 and CXCL8 were added to the lower compartment of a Boyden microchamber. Freshly isolated neutrophils in the presence or absence of the FPR2 antagonist WRW 4 (20 μg/ml, 18110 nM) were added to the upper compartment and allowed to migrate for 45 min. The chemotactic potencies are expressed as mean chemotactic index + SEM and are derived from three independent experiments. Control recruitment is indicated by a dashed line (—). (C) Neutrophils were stimulated (3 min) with homogenous hrSAA1 (300 or 3000 ng/ml, 25 or 250 nM), CXCL8 (1 or 3 ng/ml, 0.12 or 0.36 nM) or a combination of hrSAA1 and CXCL8. Data from six independent experiments are expressed as the net percentage of activated cells (blebbed and elongated cells) (+SEM). (D) Freshly isolated neutrophils were stimulated for 30 s with different concentrations of hrSAA1, CXCL8 or a combination of hrSAA1 and CXCL8. Following stimulation, cells were stained with Alexa Fluor 555 Phalloidin. Control actin polymerization is indicated by a dashed line (—). Results are presented as the mean percent florescence intensity relative to buffer-stimulated cells (+SEM) and are derived from six independent experiments. Significant neutrophil recruitment/activation in comparison to control is indicated by asterisks (Mann-Whitney U -test; * p -value < 0.05, ** p -value < 0.01). Significant synergy between hrSAA1 and CXCL8 in neutrophil activation/recruitment is indicated by daggers (Mann-Whitney U -test; † p -value < 0.05, †† p -value < 0.01).

    Journal: Frontiers in Immunology

    Article Title: Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1

    doi: 10.3389/fimmu.2020.00843

    Figure Lengend Snippet: hrSAA1 retains the capacity to synergize with CXCL8 in the in vitro attraction and activation of neutrophils. (A) Homogenous rSAA1 (hrSAA1, 300 or 3000 ng/ml, 25 or 250 nM) and CXCL8 (1–10 ng/ml, 0.12–1.2 nM) were added to the lower compartment of a Boyden microchamber either alone or in combination. Freshly isolated neutrophils were added to the upper compartment and allowed to migrate for 45 min. The chemotactic potencies are expressed as mean chemotactic index (+SEM) derived from six independent experiments. Control recruitment is indicated by a dashed line (—). (B) MMK-1 (16 μg/ml, 9930 nM), hrSAA1 (3000 ng/ml, 250 nM), CXCL8 (3 or 9 ng/ml, 0.36 or 1.07 nM) or a combination of hrSAA1 and CXCL8 were added to the lower compartment of a Boyden microchamber. Freshly isolated neutrophils in the presence or absence of the FPR2 antagonist WRW 4 (20 μg/ml, 18110 nM) were added to the upper compartment and allowed to migrate for 45 min. The chemotactic potencies are expressed as mean chemotactic index + SEM and are derived from three independent experiments. Control recruitment is indicated by a dashed line (—). (C) Neutrophils were stimulated (3 min) with homogenous hrSAA1 (300 or 3000 ng/ml, 25 or 250 nM), CXCL8 (1 or 3 ng/ml, 0.12 or 0.36 nM) or a combination of hrSAA1 and CXCL8. Data from six independent experiments are expressed as the net percentage of activated cells (blebbed and elongated cells) (+SEM). (D) Freshly isolated neutrophils were stimulated for 30 s with different concentrations of hrSAA1, CXCL8 or a combination of hrSAA1 and CXCL8. Following stimulation, cells were stained with Alexa Fluor 555 Phalloidin. Control actin polymerization is indicated by a dashed line (—). Results are presented as the mean percent florescence intensity relative to buffer-stimulated cells (+SEM) and are derived from six independent experiments. Significant neutrophil recruitment/activation in comparison to control is indicated by asterisks (Mann-Whitney U -test; * p -value < 0.05, ** p -value < 0.01). Significant synergy between hrSAA1 and CXCL8 in neutrophil activation/recruitment is indicated by daggers (Mann-Whitney U -test; † p -value < 0.05, †† p -value < 0.01).

    Article Snippet: The human CXCL8 ELISA was developed in our laboratory using monoclonal mouse anti-human CXCL8 (MAB208) and polyclonal goat anti-human CXCL8 (BAF208) antibodies from R&D Systems ( ).

    Techniques: In Vitro, Activation Assay, Isolation, Derivative Assay, Control, Staining, Comparison, MANN-WHITNEY, Significance Assay

    Comparison of the biological activities of E. coli -expressed SAA1 before (SAA1) and after (hrSAA1) purification to homogeneity using RP-HPLC.

    Journal: Frontiers in Immunology

    Article Title: Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1

    doi: 10.3389/fimmu.2020.00843

    Figure Lengend Snippet: Comparison of the biological activities of E. coli -expressed SAA1 before (SAA1) and after (hrSAA1) purification to homogeneity using RP-HPLC.

    Article Snippet: The human CXCL8 ELISA was developed in our laboratory using monoclonal mouse anti-human CXCL8 (MAB208) and polyclonal goat anti-human CXCL8 (BAF208) antibodies from R&D Systems ( ).

    Techniques: Comparison, Purification, In Vivo, Migration, Expressing

    Impure mu rSAA3 induces chemokines in human CD14 + monocytes. Human CD14 + monocytes derived from buffy coats of healthy individuals were stimulated with LPS (500 ng/ml), hu rSAA1 (100 or 1000 ng/ml), mu rSAA3 (10-1000 ng/ml) or were left untreated (Co). After 24 h, supernatants were collected and levels of CXCL8, CCL3 and CCL2 were determined via specific ELISAs. Data represent the mean production of chemokine ± SEM derived from 4 independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05).

    Journal: Mediators of Inflammation

    Article Title: Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case

    doi: 10.1155/2020/6087109

    Figure Lengend Snippet: Impure mu rSAA3 induces chemokines in human CD14 + monocytes. Human CD14 + monocytes derived from buffy coats of healthy individuals were stimulated with LPS (500 ng/ml), hu rSAA1 (100 or 1000 ng/ml), mu rSAA3 (10-1000 ng/ml) or were left untreated (Co). After 24 h, supernatants were collected and levels of CXCL8, CCL3 and CCL2 were determined via specific ELISAs. Data represent the mean production of chemokine ± SEM derived from 4 independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05).

    Article Snippet: The human CXCL8 ELISA was developed in our laboratory using monoclonal mouse anti-human CXCL8 (MAB208) and biotinylated polyclonal goat anti-human CXCL8 (BAF208) antibodies purchased from R&D Systems (Minneapolis, MN, USA) [ ].

    Techniques: Derivative Assay, Control, MANN-WHITNEY

    Impure mu rSAA3 is a potent neutrophil chemoattractant in vitro and in vivo and synergizes with CXCL8 in neutrophil migration. (a and b) The chemotactic activity of hu rSAA1 (1000 or 3000 ng/ml) and mu rSAA3 (30-3000 ng/ml) on human neutrophils was evaluated in the Boyden Microchamber Assay. The lower compartment of the microchamber was filled with chemoattractant alone (a) or with a combination of mu rSAA3 (30-3000 ng/ml) and CXCL8 (0.2-3 ng/ml) to assess synergy (b). The chemotactic potency is expressed as chemotactic index and is shown with (a) or without (b) SEM for 5-6 independent experiments. Statistically significant migration (compared to controls) and statistically significant synergy (compared to the sum of the values when both chemoattractants are tested separately), determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05; ∗∗ p < 0.01) and daggers ( † p < 0.05), respectively. (c) Female NMRI mice were injected i.p. with 100 μ l of mu rSAA3 (1-1000 ng), hu rSAA1 (100 ng) or PBS (Co; 2-8 mice per group). After 2 h, mice were sacrificed and peritoneal lavages were performed. Total cell counts in peritoneal lavages were determined and cytospins were prepared for differential leukocyte counts by 2 individuals independently. Data represent the mean percentage (black bars) or absolute number × 10 4 /ml (hatched bars) of neutrophils ± SEM derived from 2 to 3 independent experiments. Statistically significant recruitment of neutrophils compared to PBS-injected mice, determined by the Mann-Whitney U test, is indicated by asterisks ( ∗∗ p < 0.01).

    Journal: Mediators of Inflammation

    Article Title: Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case

    doi: 10.1155/2020/6087109

    Figure Lengend Snippet: Impure mu rSAA3 is a potent neutrophil chemoattractant in vitro and in vivo and synergizes with CXCL8 in neutrophil migration. (a and b) The chemotactic activity of hu rSAA1 (1000 or 3000 ng/ml) and mu rSAA3 (30-3000 ng/ml) on human neutrophils was evaluated in the Boyden Microchamber Assay. The lower compartment of the microchamber was filled with chemoattractant alone (a) or with a combination of mu rSAA3 (30-3000 ng/ml) and CXCL8 (0.2-3 ng/ml) to assess synergy (b). The chemotactic potency is expressed as chemotactic index and is shown with (a) or without (b) SEM for 5-6 independent experiments. Statistically significant migration (compared to controls) and statistically significant synergy (compared to the sum of the values when both chemoattractants are tested separately), determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05; ∗∗ p < 0.01) and daggers ( † p < 0.05), respectively. (c) Female NMRI mice were injected i.p. with 100 μ l of mu rSAA3 (1-1000 ng), hu rSAA1 (100 ng) or PBS (Co; 2-8 mice per group). After 2 h, mice were sacrificed and peritoneal lavages were performed. Total cell counts in peritoneal lavages were determined and cytospins were prepared for differential leukocyte counts by 2 individuals independently. Data represent the mean percentage (black bars) or absolute number × 10 4 /ml (hatched bars) of neutrophils ± SEM derived from 2 to 3 independent experiments. Statistically significant recruitment of neutrophils compared to PBS-injected mice, determined by the Mann-Whitney U test, is indicated by asterisks ( ∗∗ p < 0.01).

    Article Snippet: The human CXCL8 ELISA was developed in our laboratory using monoclonal mouse anti-human CXCL8 (MAB208) and biotinylated polyclonal goat anti-human CXCL8 (BAF208) antibodies purchased from R&D Systems (Minneapolis, MN, USA) [ ].

    Techniques: In Vitro, In Vivo, Migration, Activity Assay, MANN-WHITNEY, Injection, Derivative Assay

    Low concentrations of LPS induce CXCL8 in CD14 + monocytes. Human CD14 + monocytes derived from buffy coats from healthy donors were stimulated with LPS (0.7-7000 pg/ml) or were left untreated (Co). After 24 h, supernatants were collected and levels of CXCL8 were determined via a specific ELISA. Data represent the mean production of CXCL8 ± SEM derived from 3 to 11 independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001).

    Journal: Mediators of Inflammation

    Article Title: Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case

    doi: 10.1155/2020/6087109

    Figure Lengend Snippet: Low concentrations of LPS induce CXCL8 in CD14 + monocytes. Human CD14 + monocytes derived from buffy coats from healthy donors were stimulated with LPS (0.7-7000 pg/ml) or were left untreated (Co). After 24 h, supernatants were collected and levels of CXCL8 were determined via a specific ELISA. Data represent the mean production of CXCL8 ± SEM derived from 3 to 11 independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001).

    Article Snippet: The human CXCL8 ELISA was developed in our laboratory using monoclonal mouse anti-human CXCL8 (MAB208) and biotinylated polyclonal goat anti-human CXCL8 (BAF208) antibodies purchased from R&D Systems (Minneapolis, MN, USA) [ ].

    Techniques: Derivative Assay, Enzyme-linked Immunosorbent Assay, Control, MANN-WHITNEY

    In contrast to impure mu rSAA3, RP-HPLC-purified mu rSAA3 (mu rSAA3 pur ) does not induce chemokines in leukocytes. Human CD14 + monocytes derived from buffy coats from healthy individuals (a) or murine peritoneal cells derived from healthy mice (b) were stimulated with LPS (500 ng/ml), mu rSAA3 (10 or 100 ng/ml), mu rSAA3 pur (10 or 100 ng/ml) or were left untreated (Co). After 24 h, supernatants were collected and levels of CXCL8 (a) or CXCL2 (b) were determined via specific ELISAs. Data represent the mean production of chemokine ± SEM derived from 4 (a) or 3 (b) independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05).

    Journal: Mediators of Inflammation

    Article Title: Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case

    doi: 10.1155/2020/6087109

    Figure Lengend Snippet: In contrast to impure mu rSAA3, RP-HPLC-purified mu rSAA3 (mu rSAA3 pur ) does not induce chemokines in leukocytes. Human CD14 + monocytes derived from buffy coats from healthy individuals (a) or murine peritoneal cells derived from healthy mice (b) were stimulated with LPS (500 ng/ml), mu rSAA3 (10 or 100 ng/ml), mu rSAA3 pur (10 or 100 ng/ml) or were left untreated (Co). After 24 h, supernatants were collected and levels of CXCL8 (a) or CXCL2 (b) were determined via specific ELISAs. Data represent the mean production of chemokine ± SEM derived from 4 (a) or 3 (b) independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05).

    Article Snippet: The human CXCL8 ELISA was developed in our laboratory using monoclonal mouse anti-human CXCL8 (MAB208) and biotinylated polyclonal goat anti-human CXCL8 (BAF208) antibodies purchased from R&D Systems (Minneapolis, MN, USA) [ ].

    Techniques: Purification, Derivative Assay, Control, MANN-WHITNEY

    In contrast to impure mu rSAA3, RP-HPLC-purified mu rSAA3 (mu rSAA3 pur ) does not chemoattract neutrophils in vivo . (a) Female NMRI mice were injected i.p. with 100 μ l of PBS (Co), mu rSAA3 (10 or 100 ng) or RP-HPLC-purified mu rSAA3 pur (10 or 100 ng; 3-5 mice per group). After 2 h, mice were sacrificed and peritoneal lavages were performed. Total cell counts in peritoneal lavages were determined and the percentage of neutrophils (Ly-6G + CD11b + ) was quantified via flow cytometry. (b) Female NMRI mice were injected i.p. with 100 μ l of PBS (Co) or LPS (2 or 10 pg; 4-8 mice per group). After 2 h, mice were sacrificed and peritoneal lavages were performed. Total cell counts in peritoneal lavages were determined, and cytospins were prepared for differential leukocyte counts by 2 individuals independently. (a and b) Data represent the mean percentage (black bars) or absolute number × 10 4 /ml (hatched bars) of neutrophils ± SEM derived from 1 (a) or 1-3 (b) independent experiment(s). Statistically significant recruitment of neutrophils compared to PBS-injected mice, determined by the Mann-Whitney U test, is indicated by asterisks ( ∗ p < 0.05; ∗∗ p < 0.01). (c) Human CD14 + monocytes derived from buffy coats from healthy individuals were stimulated with LPS (500 ng/ml), mu rSAA3 (10 or 100 ng/ml), mu rSAA3 pur (10 or 100 ng/ml) or were left untreated (Co). After 2 h, supernatants were collected and levels of CXCL8 were determined via a specific ELISA. Data represent the mean production of chemokine ± SEM derived from 4 independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05).

    Journal: Mediators of Inflammation

    Article Title: Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case

    doi: 10.1155/2020/6087109

    Figure Lengend Snippet: In contrast to impure mu rSAA3, RP-HPLC-purified mu rSAA3 (mu rSAA3 pur ) does not chemoattract neutrophils in vivo . (a) Female NMRI mice were injected i.p. with 100 μ l of PBS (Co), mu rSAA3 (10 or 100 ng) or RP-HPLC-purified mu rSAA3 pur (10 or 100 ng; 3-5 mice per group). After 2 h, mice were sacrificed and peritoneal lavages were performed. Total cell counts in peritoneal lavages were determined and the percentage of neutrophils (Ly-6G + CD11b + ) was quantified via flow cytometry. (b) Female NMRI mice were injected i.p. with 100 μ l of PBS (Co) or LPS (2 or 10 pg; 4-8 mice per group). After 2 h, mice were sacrificed and peritoneal lavages were performed. Total cell counts in peritoneal lavages were determined, and cytospins were prepared for differential leukocyte counts by 2 individuals independently. (a and b) Data represent the mean percentage (black bars) or absolute number × 10 4 /ml (hatched bars) of neutrophils ± SEM derived from 1 (a) or 1-3 (b) independent experiment(s). Statistically significant recruitment of neutrophils compared to PBS-injected mice, determined by the Mann-Whitney U test, is indicated by asterisks ( ∗ p < 0.05; ∗∗ p < 0.01). (c) Human CD14 + monocytes derived from buffy coats from healthy individuals were stimulated with LPS (500 ng/ml), mu rSAA3 (10 or 100 ng/ml), mu rSAA3 pur (10 or 100 ng/ml) or were left untreated (Co). After 2 h, supernatants were collected and levels of CXCL8 were determined via a specific ELISA. Data represent the mean production of chemokine ± SEM derived from 4 independent experiments. Statistically significant differences from untreated control cells, determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05).

    Article Snippet: The human CXCL8 ELISA was developed in our laboratory using monoclonal mouse anti-human CXCL8 (MAB208) and biotinylated polyclonal goat anti-human CXCL8 (BAF208) antibodies purchased from R&D Systems (Minneapolis, MN, USA) [ ].

    Techniques: Purification, In Vivo, Injection, Flow Cytometry, Derivative Assay, MANN-WHITNEY, Enzyme-linked Immunosorbent Assay, Control

    Mu rSAA3 pur synergizes with CXCL8 in neutrophil activation. Activation of human neutrophils was assessed via shape change assays. Neutrophils were stimulated for a period of 3 min with different concentrations of CXCL8 (1 or 3 ng/ml), mu rSAA3 pur (30-3000 ng/ml) or were left untreated. After fixation of cells, non-activated resting (round) and activated (blebbed and elongated) neutrophils were counted microscopically by 2 individuals independently. (a) Data represent the mean net percentage of activated neutrophils ± SEM derived from 4 independent experiments. Statistically significant activation of neutrophils (compared to controls) and statistically significant synergy (compared to the sum of the values when both agonists are tested separately), determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05) and daggers ( † p < 0.05), respectively. (b) Phase contrast image (20x magnification; scale bar: 20 μ m) of one representative experiment illustrating the morphological change of neutrophils following stimulation with buffer (control), CXCL8 (3 ng/ml), mu rSAA3 pur (3000 ng/ml) or a combination of CXCL8 and mu rSAA3 pur are shown.

    Journal: Mediators of Inflammation

    Article Title: Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case

    doi: 10.1155/2020/6087109

    Figure Lengend Snippet: Mu rSAA3 pur synergizes with CXCL8 in neutrophil activation. Activation of human neutrophils was assessed via shape change assays. Neutrophils were stimulated for a period of 3 min with different concentrations of CXCL8 (1 or 3 ng/ml), mu rSAA3 pur (30-3000 ng/ml) or were left untreated. After fixation of cells, non-activated resting (round) and activated (blebbed and elongated) neutrophils were counted microscopically by 2 individuals independently. (a) Data represent the mean net percentage of activated neutrophils ± SEM derived from 4 independent experiments. Statistically significant activation of neutrophils (compared to controls) and statistically significant synergy (compared to the sum of the values when both agonists are tested separately), determined by the Mann-Whitney U test, are indicated by asterisks ( ∗ p < 0.05) and daggers ( † p < 0.05), respectively. (b) Phase contrast image (20x magnification; scale bar: 20 μ m) of one representative experiment illustrating the morphological change of neutrophils following stimulation with buffer (control), CXCL8 (3 ng/ml), mu rSAA3 pur (3000 ng/ml) or a combination of CXCL8 and mu rSAA3 pur are shown.

    Article Snippet: The human CXCL8 ELISA was developed in our laboratory using monoclonal mouse anti-human CXCL8 (MAB208) and biotinylated polyclonal goat anti-human CXCL8 (BAF208) antibodies purchased from R&D Systems (Minneapolis, MN, USA) [ ].

    Techniques: Activation Assay, Derivative Assay, MANN-WHITNEY, Control